US Map / Nevada
State NV

Clinical Trials in Nevada

Nevada is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Nevada and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 85 actively recruiting studies with Nevada sites out of 85 registered in total. The busiest research areas in Nevada are Obesity, Breast Cancer, Acute Myeloid Leukemia. Leading sponsors running trials in the state include AstraZeneca, Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network. By stage, Nevada trials break down as Phase 1 (7), Phase 2 (22), Phase 3 (40), Phase 4 (6).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
85
Recruiting Now
85
← Back to US Map
Top Conditions in Nevada
Obesity (3)Breast Cancer (3)Acute Myeloid Leukemia (3)Endometrial Cancer (3)Systemic Lupus Erythematosus (2)ADHD (2)Overweight (2)Crohn's Disease (2)Atherosclerotic Cardiovascular Disease (1)Major Depressive Disorder (MDD) (1)Diabetic Retinopathy (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in Nevada

How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 85 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 85. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Obesity, Breast Cancer, Acute Myeloid Leukemia, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nevada

NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06781580 N/A
Recruiting
Ergonomic Protocol for Competitive E-Sport Athletes
Condition
No Disease or Condition is Being Studied
Enrollment
12 pts
Location
United States
Sponsor
University of Nevada, Las Vega
View Trial →
NCT05677490 Phase 3
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanc...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
382 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06775379 Phase 3
Recruiting
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Condition
Major Depressive Disorder
Enrollment
450 pts
Location
United States
Sponsor
Xenon Pharmaceuticals Inc.
View Trial →
NCT06712654 Phase 2
Recruiting
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in...
Condition
Hyperphosphatemia
Enrollment
168 pts
Location
United States, China
Sponsor
R1 Therapeutics
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT06312722 N/A
Recruiting
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market S...
Condition
Benign Prostatic Hyperplasia
Enrollment
92 pts
Location
United States
Sponsor
Urotronic Inc.
View Trial →
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07784725 Phase 3
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Over...
Condition
Obesity or Overweight
Enrollment
2,500 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05558527 N/A
Recruiting
The Social Regulation of Threat-related Vigilance and Arousal
Condition
Psychological Trauma, Historical
Enrollment
45 pts
Location
United States
Sponsor
University of Nevada, Reno
View Trial →
NCT07284602 Phase 3
Recruiting
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared t...
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
1,100 pts
Location
United States
Sponsor
PureTech
View Trial →
NCT07491445 Phase 3
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients...
Condition
Pancreatic Cancer
Enrollment
900 pts
Location
United States, Australia, Brazil
Sponsor
Revolution Medicines, Inc.
View Trial →
NCT05377996 Phase 1, Phase 2
Recruiting
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Condition
Triple Negative Breast Cancer
Enrollment
360 pts
Location
United States
Sponsor
Day One Biopharmaceuticals, In
View Trial →
NCT06318169 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Enrollment
1,350 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
View Trial →
NCT07004192 Phase 4
Recruiting
The Role of hCG in Thawed Embryo Transfer
Condition
Infertility (IVF Patients)
Enrollment
220 pts
Location
United States
Sponsor
Fertility Center of Las Vegas
View Trial →
NCT06485843 Phase 2
Recruiting
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate...
Condition
Osteoarthritis
Enrollment
400 pts
Location
United States
Sponsor
Ageless Biotech, Inc.
View Trial →
NCT07743450 Phase 3
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Pa...
Condition
Obesity
Enrollment
1,560 pts
Location
United States, Czechia, Germany
Sponsor
Ascletis Pharma (China) Co., L
View Trial →
NCT07078682 N/A
Recruiting
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Ha...
Condition
Uterine Fibroids
Enrollment
42 pts
Location
United States
Sponsor
Zenchi, Inc.
View Trial →
NCT07064759 Phase 3
Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascul...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
480 pts
Location
United States, Argentina, Australia
Sponsor
4D Molecular Therapeutics
View Trial →
NCT06989112 Phase 3
Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegos...
Condition
Endometrial Cancer
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
View Trial →
NCT07699471 Phase 3
Recruiting
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients Wit...
Condition
Hypoparathyroidism
Enrollment
160 pts
Location
United States
Sponsor
MBX Biosciences
View Trial →
NCT07445971 Phase 1
Recruiting
A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Sever...
Condition
COVID -19
Enrollment
80 pts
Location
United States
Sponsor
ModeX Therapeutics, An OPKO He
View Trial →
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
Page 2 of 4 — 85 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology